Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Inhibition of Human Coronaviruses by Antimalarial Peroxides
Ayan Kumar Ghosh
, Halli Miller
, Konstance Knox
, Madhuchhanda Kundu
, Kelly J. Henrickson
, Ravit Arav-Boger
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of Human Coronaviruses by Antimalarial Peroxides'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antimalarial Peroxides
100%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
100%
Human Coronaviruses (HCoVs)
100%
Selectivity Index
83%
Ozonide
66%
EC50
50%
Artesunate
50%
Calu-3 Cells
50%
Repurposing
33%
Vero Cells
33%
Remdesivir
33%
In Vivo Model
16%
New Agents
16%
Anticancer Activity
16%
Drug Combination
16%
Intravenous Administration
16%
Skin Fibroblasts
16%
In Vitro Activity
16%
Safe Drugs
16%
Cell-Associated
16%
High Toxicity
16%
Antiviral Activity
16%
Work Support
16%
Cell-type Specificity
16%
Vero
16%
Virus Interference
16%
NL63
16%
HCoV-OC43
16%
Human Coronavirus OC43
16%
Human Coronavirus NL63
16%
OZ439
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antimalarial Agent
100%
Peroxide
100%
SARS Coronavirus
100%
Coronaviridae
100%
Arterolane
80%
Ozonide
80%
Artesunate
60%
EC50
60%
Remdesivir
40%
Combination Drug
20%
Antivirus Agent
20%
Repurposing
20%
Severe Acute Respiratory Syndrome
20%
Human Coronavirus NL63
20%
Virus
20%
Immunology and Microbiology
Human Coronavirus NL63
20%